Ms Contin (Morphine Sulfate)

Morphine sulfate, the active ingredient in Ms Contin, is an opioid analgesic presented as an extended‑release oral tablet for oral use. It treats moderate to severe acute pain, chronic cancer pain, and severe postoperative pain in adult patients.

GNH USA supplies Ms Contin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres, pharmacies and specialty clinics worldwide.

Ms Contin is an opioid analgesic used to manage pain that originates from severe nociceptive pathways.

- Moderate to severe acute pain: provides sustained analgesia for short‑term severe pain episodes. - Chronic cancer pain: offers continuous pain control for patients with malignant disease. - Severe postoperative pain: maintains opioid levels to control pain after major surgery.

Common Side Effects: - Nausea: feeling of sickness or urge to vomit. - Constipation: reduced bowel movements and hard stools. - Drowsiness: increased sleepiness or fatigue. - Dry mouth: reduced salivation leading to a parched feeling.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure causing dizziness or fainting. - Dependence or addiction: development of physical or psychological reliance on the drug. - Anaphylaxis: rare severe allergic reaction with hives, swelling, and airway compromise.

Ms Contin requires careful clinical oversight to ensure safe use.

- Assess pain level: evaluate severity and type before initiating therapy. - Monitor respiratory function: watch for signs of slowed breathing, especially after dose adjustments. - Evaluate opioid tolerance: consider prior opioid exposure when selecting dose. - Avoid concurrent CNS depressants: limit use with benzodiazepines, barbiturates, or alcohol. - Adjust dose in renal/hepatic impairment: reduce dose or increase monitoring in patients with organ dysfunction. - Store at ambient temperature: keep in the original pack, protect from moisture.

Ms Contin may interact with several drug classes, requiring vigilance.

Major Interactions (Avoid): - Other opioids: additive respiratory depression. - Central nervous system depressants (e.g., benzodiazepines): increased sedation and respiratory risk. - Monoamine oxidase inhibitors (MAOIs): risk of severe hypotension. - Alcohol: potentiates sedative effects.

Moderate Interactions (Monitor Closely): - CYP3A4 inhibitors (e.g., erythromycin, ketoconazole): may raise morphine levels. - CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce analgesic effect.